We cordially invite you to attend the Umeå Infection Symposium on 27 August 2024. Get inspired by the invited keynote speaker and learn about novel research approaches and directions at Umeå University.
Register now! Deadline: 14 August 2024
MIMS
The Laboratory for Molecular Infection Medicine Sweden
MIMS is the Swedish partner in the Nordic EMBL Partnership for Molecular Medicine
Image:
Mattias Pettersson
Call 2024 - MIMS Clinical Research Fellowship
Call 2024 - MIMS Clinical Research Fellowship
Develop a research programme in the broad area of infection medicine in collaboration with a basic researcher.
Umeå Infection Symposium 2024
The fight against malaria requires deeper knowledge of the parasite's life cycle
To combat malaria, knowledge of the parasite that causes the disease is crucial. Oliver Billker’s quest to decode its complex biology began as a student in Berlin and led him to Umeå. “I was absolutely amazed that we had no understanding at the molecular level of the lifecycles of parasites, although they kill so many people every year,” he says.
New Group Leaders joining infection research at Umeå University
The Laboratory for Molecular Infection Medicine Sweden (MIMS) welcomes Ryo Morimoto and Iker Valle Aramburu as new Group Leaders! The two new MIMS Group Leaders are starting their independent research groups at the field of infection biology in 2024, and they are both excited to take on the group leader role and establish their research groups in the collaborative and strong research environment at Umeå University.
HOT OFF THE PRESS
Key bacterium discovered – maintains the protective intestinal mucus barrier under low-fibre diet
Key bacterium discovered – maintains the protective intestinal mucus barrier under low-fibre diet
SM Holmberg, RH Feeney, PKV Prasoodanan, ... BO Schröder (2024) Nature Communication 15, 3502
A scalable CRISPR-Cas9 gene editing system facilitates CRISPR screens in the malaria parasite Plasmodium berghei
A scalable CRISPR-Cas9 gene editing system facilitates CRISPR screens in the malaria parasite Plasmodium berghei
TK Jonsdottir, MS Paoletta, T Ishizaki, S Hernandez, M Ivanova, ..., ESC Bushell (2024)
MIMS is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine
MIMS is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine
Nordic EMBL Partnership, a major strategic player in Europe’s molecular understanding of disease mechanisms
Discovery at Umeå University awarded 2020 Nobel Prize in Chemistry
Emmanuelle Charpentier has been awarded the 2020 Nobel Prize in Chemistry, together with Jennifer Doudna, for her groundbreaking work on the CRISPR-Cas9 gene editing technology
Emmanuelle Charpentier has been awarded the 2020 Nobel Prize in Chemistry, together with Jennifer Doudna, for her groundbreaking work on the CRISPR-Cas9 gene editing technology
Honorary doctor at Umeå University, former group leader at MIMS and former visiting professor at UCMR
MIMS Annual Report 2021-2022
MIMS Annual Report 2021-2022
The MIMS Annual Report for 2021-2022 is now published online
Research Areas
Research Areas
Discover the different research areas MIMS scientists are engaged with
Our Stories
Our Stories
Read the latest stories about our research and researchers
Work With Us
Work With Us
Find out what open position are available
Nordic EMBL Partnership for Molecular Medicine
Supporting organisations
